Suzhou Maximum Bio-tech Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Suzhou Maximum Bio-tech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors (NCT06742593) | Suzhou Maximum Bio-tech Co., Ltd. | 2025-01-01 |
| Study of MT027 in Patients with Recurrent or Progressive High-grade Glioma (NCT06737146) | Suzhou Maximum Bio-tech Co., Ltd. | 2025-01-01 |
| A Study of MT027 in Patients with Pleural Malignant Tumors (NCT06726564) | Suzhou Maximum Bio-tech Co., Ltd. | 2024-05-15 |
Track Suzhou Maximum Bio-tech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.